Latest Financials News

Miramar Resources has secured $409,000 through a Share Purchase Plan to fund further exploration at its promising Gidji JV Gold Project, while advancing a strategic joint venture with Sumitomo at Bangemall.

Vection Technologies has expanded its AI contract portfolio by securing an additional $2.1 million through a deepened exclusive partnership with Area12 Consulting, bringing total contracts since May 2025 to $5.7 million.

Cyclone Metals has launched a comprehensive Pre-Feasibility Study for its Iron Bear iron ore project in Canada, aiming to refine development plans and attract global steel market demand.

Black Cat Syndicate’s ongoing underground drilling at Paulsens has revealed extraordinary gold grades, including a standout 1.60m intercept at 623.94g/t Au. These results underpin the mine’s ramp-up and resource expansion plans.

RooLife Group Ltd reported a sharp 51% revenue decline to $4.62 million and a 31% increase in net loss to $2.76 million for FY2025, as it pivots towards higher-margin sectors including renewable energy and global social commerce.

Recce Pharmaceuticals reported a 21% increase in net loss to $21.4 million for FY2025, driven by intensified R&D spending. The company secured key regulatory approvals for Phase 3 trials of its lead anti-infective gel and bolstered its financial position with significant capital raises and grants.

Fat Prophets Global Contrarian Fund Ltd has reported a robust 56% increase in net profit for the year ended 30 June 2025, driven by strong investment returns and a leveraged global equity portfolio. The company also declared a fully franked special dividend, reflecting confidence in its ongoing performance.

PT Aneka Tambang Tbk (ANTAM) reported a remarkable 240% surge in net profit for the half year ended June 30, 2025, driven by robust gold and nickel sales amid a challenging mining sector.

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

Botanix Pharmaceuticals posted a sharp revenue increase driven by its new hyperhidrosis treatment Sofdra, yet reported a substantial net loss reflecting heavy investment in commercialisation. The company’s strong cash position underpins its path to profitability.

Merino & Co. Limited reported a significant 36% decline in revenues alongside a $2.76 million loss for the fiscal year ended June 2025, marking a stark reversal from the prior year’s modest profit.

Holista Colltech reports a sharp 70% reduction in net loss and an 8.6% revenue rise, driven by strong supplements sales and a landmark collagen partnership with Regenerex Pharma.